Peter W. Eide

3.0k citations

19 papers · 2.0k indexed · 1 hit paper · h-index 14

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- MicroRNA in disease regulation
Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers

Papers in ⓘ

Cancer Research 12
- Cancer Genomics and Diagnostics 10
- Cancer-related molecular mechanisms research 2
Pathology and Forensic Medicine 9
- Genetic factors in colorectal cancer 9

Co-authors: Ragnhild A. Lothe (19 shared papers)Stine A. Danielsen (7 shared papers)Ina A. Eilertsen (12 shared papers)Guro E. Lind (3 shared papers)Anita Sveen (13 shared papers)Jarle Bruun (9 shared papers)Merete Hektoen (3 shared papers)M. Eknæs (1 shared paper)
Journals: Molecular Oncology (2 papers)Oncogenesis (2 papers)ESMO Open (2 papers)Genome Medicine (2 papers)Clinical Cancer Research (1 paper)
Partner nations: Norway Finland Sweden

In The Last Decade

Peter W. Eide

19 papers receiving 2.0k citations

Hit Papers

align trajectories log scale

Epigenetic and genetic features of 24 colon cancer cell lines 2013 · 682 citations

Peers

Countries citing papers authored by Peter W. Eide

Since Specialization

Citations

This map shows the geographic impact of Peter W. Eide's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter W. Eide with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter W. Eide more than expected).

Fields of papers citing papers by Peter W. Eide

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter W. Eide. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter W. Eide. The network helps show where Peter W. Eide may publish in the future.

Co-authors

The 25 scholars most cited alongside Peter W. Eide, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Peter W. Eide Line = papers co-authored together Peter W. Eide links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Epigenetic and genetic features of 24 colon cancer cell lines Oncogenesis ·D. Ahmed, Peter W. Eide, Ina A. Eilertsen, Stine A. Danielsen, M. Eknæs, Merete Hektoen, Guro E. Lind, Ragnhild A. Lothe Hit paper breakdown →	2013	682
2	Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies Molecular Cancer ·Kaja C. G. Berg, Peter W. Eide, Ina A. Eilertsen, Bjarne Johannessen, Jarle Bruun, Stine A. Danielsen, Merete Bjørnslett, Leonardo A. Meza‐Zepeda, Mette Eknæs, Guro E. Lind, Ola Myklebost, Rolf I. Skotheim, Anita Sveen, Ragnhild A. Lothe	2017	284
3	Portrait of the PI3K/AKT pathway in colorectal cancer Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Stine A. Danielsen, Peter W. Eide, Arild Nesbakken, Tormod Kyrre Guren, Edward Leithe, Ragnhild A. Lothe	2014	263
4	CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models Scientific Reports ·Peter W. Eide, Jarle Bruun, Ragnhild A. Lothe, Anita Sveen	2017	189
5	Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies Clinical Cancer Research ·Anita Sveen, Jarle Bruun, Peter W. Eide, Ina A. Eilertsen, Lorena Ramírez, Astrid Murumägi, Mariliina Arjama, Stine A. Danielsen, Kushtrim Kryeziu, Élena Elez, Josep Tabernero, Justin Guinney, Héctor G. Pálmer, Arild Nesbakken, Olli Kallioniemi, Rodrigo Dienstmann, Ragnhild A. Lothe	2017	173
6	MicroRNAs as growth regulators, their function and biomarker status in colorectal cancer Oncotarget ·Lina Cekaite, Peter W. Eide, Guro E. Lind, Rolf I. Skotheim, Ragnhild A. Lothe	2015	86
7	NEDD4 is overexpressed in colorectal cancer and promotes colonic cell growth independently of the PI3K/PTEN/AKT pathway Cellular Signalling ·Peter W. Eide, Lina Cekaite, Stine A. Danielsen, Ina A. Eilertsen, Ane Kjenseth, Tone A. Fykerud, Trude H. Ågesen, Jarle Bruun, Edgar Rivedal, Ragnhild A. Lothe, Edward Leithe	2012	63
8	Metastatic heterogeneity of the consensus molecular subtypes of colorectal cancer npj Genomic Medicine ·Peter W. Eide, Seyed H. Moosavi, Ina A. Eilertsen, Tuva H. Brunsell, Jonas Langerud, Kaja C. G. Berg, Bård I. Røsok, Bjørn Atle Bjørnbeth, Arild Nesbakken, Ragnhild A. Lothe, Anita Sveen	2021	38
9	Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer Molecular Oncology ·Jarle Bruun, Anita Sveen, Rita Barros, Peter W. Eide, Ina A. Eilertsen, Matthias Kolberg, Teijo Pellinen, Leonor David, Aud Svindland, Olli Kallioniemi, Marianne G. Guren, Arild Nesbakken, Raquel Almeida, Ragnhild A. Lothe	2018	35
10	Long noncoding RNA MIR31HG is a bona fide prognostic marker with colorectal cancer cell‐intrinsic properties International Journal of Cancer ·Peter W. Eide, Ina A. Eilertsen, Anita Sveen, Ragnhild A. Lothe	2018	33
11	Molecular correlates of sensitivity to PARP inhibition beyond homologous recombination deficiency in pre-clinical models of colorectal cancer point to wild-type TP53 activity EBioMedicine ·Jørgen Smeby, Kushtrim Kryeziu, Kaja C. G. Berg, Ina A. Eilertsen, Peter W. Eide, Bjarne Johannessen, Marianne G. Guren, Arild Nesbakken, Jarle Bruun, Ragnhild A. Lothe, Anita Sveen	2020	27
12	De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity Genome Medicine ·Seyed H. Moosavi, Peter W. Eide, Ina A. Eilertsen, Tuva H. Brunsell, Kaja C. G. Berg, Bård I. Røsok, Kristoffer W. Brudvik, Bjørn Atle Bjørnbeth, Marianne G. Guren, Arild Nesbakken, Ragnhild A. Lothe, Anita Sveen	2021	21
13	Transcriptional and functional consequences of TP53 splice mutations in colorectal cancer Oncogenesis ·Jørgen Smeby, Anita Sveen, Ina A. Eilertsen, Stine A. Danielsen, Andreas Hoff, Peter W. Eide, Bjarne Johannessen, Merete Hektoen, Rolf I. Skotheim, Marianne G. Guren, Arild Nesbakken, Ragnhild A. Lothe	2019	21
14	The E3 ubiquitin ligase NEDD4 induces endocytosis and lysosomal sorting of connexin 43 to promote loss of gap junctions Journal of Cell Science ·Max Z. Totland, Christian H. Bergsland, Tone A. Fykerud, Lars M. Knudsen, Nikoline Lander Rasmussen, Peter W. Eide, Zeremariam Yohannes, Vigdis Sørensen, Andreas Brech, Ragnhild A. Lothe, Edward Leithe	2017	19
15	Exploratory analyses of consensus molecular subtype-dependent associations of TP53 mutations with immunomodulation and prognosis in colorectal cancer ESMO Open ·Jørgen Smeby, Anita Sveen, Christian H. Bergsland, Ina A. Eilertsen, Stine A. Danielsen, Peter W. Eide, Merete Hektoen, Marianne G. Guren, Arild Nesbakken, Jarle Bruun, Ragnhild A. Lothe	2019	13
16	Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases Journal of Translational Medicine ·Kushtrim Kryeziu, Seyed H. Moosavi, Christian H. Bergsland, Marianne G. Guren, Peter W. Eide, Max Z. Totland, Kristoffer Lassen, Andreas Abildgaard, Arild Nesbakken, Anita Sveen, Ragnhild A. Lothe	2021	10
17	E‐cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models Molecular Oncology ·Jarle Bruun, Peter W. Eide, Christian H. Bergsland, Oscar Brück, Aud Svindland, Mariliina Arjama, Katja Välimäki, Merete Bjørnslett, Marianne G. Guren, Olli Kallioniemi, Arild Nesbakken, Ragnhild A. Lothe, Teijo Pellinen	2021	9
18	The expressed mutational landscape of microsatellite stable colorectal cancers Genome Medicine ·Anita Sveen, Bjarne Johannessen, Ina A. Eilertsen, Bård I. Røsok, Marie Gulla, Peter W. Eide, Jarle Bruun, Kushtrim Kryeziu, Leonardo A. Meza‐Zepeda, Ola Myklebost, Bjørn Atle Bjørnbeth, Rolf I. Skotheim, Arild Nesbakken, Ragnhild A. Lothe	2021	4
19	PO-127 Role of the NEDD4 family of E3 ubiquitin ligases in colorectal cancer pathogenesis and their potential as biomarkers ESMO Open ·Lars M. Knudsen, Anita Sveen, Christian H. Bergsland, May‐Britt Five, Nikoline Lander Rasmussen, Max Z. Totland, Peter W. Eide, J. Bruun, Ragnhild A. Lothe, Edward Leithe	2018	1

About Peter W. Eide

Peter W. Eide is a scholar working on Cancer Research, Pathology and Forensic Medicine, Oncology, Hepatology and Genetics, having authored 19 papers that have together received 2.0k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (10 papers), Genetic factors in colorectal cancer (9 papers), Cancer Cells and Metastasis (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Heat shock proteins research (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (1 paper). The work is most often cited by research in Cancer Research (615 citations), Oncology (843 citations), Pathology and Forensic Medicine (408 citations), Molecular Biology (1.1k citations) and Biotechnology (75 citations). Peter W. Eide has collaborated with scholars based in Norway, Finland and Sweden. Frequent co-authors include Ragnhild A. Lothe, Stine A. Danielsen, Ina A. Eilertsen, Guro E. Lind, Anita Sveen, Jarle Bruun, Merete Hektoen, M. Eknæs, Arild Nesbakken and Edward Leithe. Their work appears in journals such as Molecular Oncology, Oncogenesis, ESMO Open, Genome Medicine and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact